In-Licensing & Out-Licensing
Aceelerating Market Access
In-Licensing & Out-Licensing
At ARYVAX, we support strategic In-Licensing and Out-Licensing partnerships that enable healthcare and biopharmaceutical companies to maximize asset value and accelerate growth across global markets. Our licensing services are designed to create mutually beneficial collaborations by aligning scientific innovation with commercial opportunity.
We assist partners throughout the entire licensing lifecycle—from opportunity identification, market assessment, and due diligence to deal structuring, negotiation support, and post-agreement execution. By combining therapeutic expertise, market intelligence, and regulatory insight, ARYVAX helps identify high-potential assets and optimal partners that align with long-term strategic objectives.
For In-Licensing, we enable companies to strengthen and diversify their portfolios by accessing innovative products, technologies, and platforms with strong market potential. Our evaluation process focuses on clinical value, regulatory feasibility, market demand, and commercialization readiness to support informed decision-making.
For Out-Licensing, ARYVAX helps innovators unlock the full value of their assets by identifying suitable regional or global partners and designing licensing strategies that expand reach while maintaining strategic control. We support positioning, partner engagement, and negotiation processes to ensure sustainable value creation and long-term success.
Our approach emphasizes transparency, risk mitigation, and alignment across regulatory, commercial, and operational considerations. With a deep understanding of global healthcare markets, ARYVAX enables efficient deal execution and successful post-licensing collaboration.
By partnering with ARYVAX, clients gain a trusted advisor committed to driving strategic partnerships that accelerate innovation, enhance market access, and deliver meaningful impact for healthcare systems and patients worldwide.
